+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Uroplakin II as a specific marker of metastatic transitional cell carcinoma



Uroplakin II as a specific marker of metastatic transitional cell carcinoma



Journal of Urology 159(5 Suppl. ): 285




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144583

Download citation: RISBibTeXText


Related references

Uroplakin as a marker for typing metastatic transitional cell carcinoma on fine-needle aspiration specimens. Cancer 93(3): 216-221, June 25, 2001

Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma. Japanese Journal of Cancer Research 89(9): 879-882, Sept, 1998

Uroplakin expression in muscle-invasive and locally metastatic transitional cell carcinoma and normal human tissues. Proceedings of the American Association for Cancer Research Annual Meeting 42: 799, 2001

Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas. Verhandlungen der Deutschen Gesellschaft für Pathologie 77: 260-265, 1993

Uroplakins as a sensitive and specific marker for typing of metastatic transitional cell carcinoma on conventional fine needle aspiration material. Acta Cytologica 44(5): 876, September-October, 2000

Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients. International Journal of Urology 6(6): 286-292, 1999

Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants. American Journal of Clinical Pathology 142(6): 864-871, 2015

Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. American Journal of Clinical Pathology 113(5): 683-687, 2000

High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma. Japanese Journal of Cancer Research 93(5): 523-531, 2002

PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin. Archives of Pathology and Laboratory Medicine 134(8): 1121-1129, 2010

Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: Alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Research 58(6): 1291-1297, 1998

Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder. Journal of Urology 162(3 Part 1): 931-935, Sept, 1999